Halozyme Therapeutics Inc (HALO)

48.13 +0.10 (+0.21%) USD  |  NASDAQ  |  Dec 27, 16:00
48.19 +0.06 (+0.12%) After-Hours: 20:00
More

Halozyme Therapeutics Total Long Term Debt (Quarterly): 1.504B for Sept. 30, 2024

Total Long Term Debt (Quarterly) Chart

View Total Long Term Debt (Quarterly) for HALO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Long Term Debt (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Long Term Debt Definition

View Total Long Term Debt Definition
Start Trial

Total Long Term Debt is the current and non-current portion of debt that a company holds. Current Portion debt are obligations of a company lasting shorter than a year. This is found in a company's current liabilities on its balance sheet.

Read full definition.

Total Long Term Debt (Quarterly) Range, Past 5 Years

View Total Long Term Debt (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Long Term Debt (Quarterly) Benchmarks

View Total Long Term Debt (Quarterly) Benchmarks
Start Trial
Amicus Therapeutics Inc 389.49M
Lexicon Pharmaceuticals Inc 99.90M
Novavax Inc 169.26M
Kura Oncology Inc --
TransMedics Group Inc 508.53M